SlideShare ist ein Scribd-Unternehmen logo
1 von 19
Know AIDS for NO AIDS !

Anika Tabassum Bristy
North South University









AIDS - Acquired Immunodeficiency
Syndrome
Syndrome means – group of diseases
Its marked by opportunistic infections
It limits the body’s ability to fight infection
Final stage of HIV infection
No cure
EPIDEMIOLOGY
Worldwide,
 34.2 million people are living with HIV
around the world.
 1.8 million new cases of HIV in 2010
 2.5 million deaths in person with AIDS
in 2011.
 Nearly 30 million people with AIDS
have died worldwide since the
epidemic began.
Reference - http://aids.com/hiv-basics/basicstatistics/


No of people living with HIV
Total

35.3 million

[32.2 million – 38.8 million]

Adult

32.1 million

[29.1 million – 35.3 million]

Women

17.7 million

[16.4 million – 19.3 million]

Children

3.3 million

[3.0 million – 3.7 million]

• People newly infected with HIV in 2012
Total

2.3 million

[1.9 million – 2.7 million]

Adult

2.0 million

[1.7 million – 2.4 million]

Children

260 000

[230 000 – 320 000]

AIDS deaths in 2012 - 1.6 million
Reference - UNAIDS


The first case of HIV/AIDS in Bangladesh was detected in 1989.

HIV and AIDS estimates (2012)






Number of people living with HIV
Adults (15 to 49 age ) prevalence rate
Adults aged 15 and up living with HIV
Women aged 15 and up living with HIV
Deaths due to AIDS

8,000 [3,100 - 82,000]
- <0.1% [<0.1% - <0.1%]
- 7,600 [3,000 - 80,000]
- 2,700 [1,000 - 28,000]
- <500 [<200 - 2,300]

Reference – UNAIDS
(http://www.unaids.org/en/regionscountries/countries/bangladesh/)
Most affected –
USA, South Africa
,Eastern Africa, India
Severely affected China , Russia, Brazil,
Vietnam
Less affected –
Australia, Saudi
Arabia, Afghanistan
• Causative agent – HIV
• HIV - “Human Immunodeficiency Virus”
• A lentivirus (slowly replicating retrovirus)

•Two types of HIV have been characterized – HIV-1 & HIV-2.
HIV 1
.

HIV 2

Virulence

High

Lower

Infectivity

High

Low

Transmission

Easily

Less easily

Prevalence

Global

West Africa

Development

Comparatively fast

Slow
Professor Luc Montagnier - discovered HIV in 1983.

• How HIV causes AIDS ?
- HIV destroys a certain kind of blood
cell (CD4 + T cells) which is crucial to the
normal function of the human immune
system.
• Loss of these cells in people with HIV
leads to the development of AIDS.

AIDS is the final state of HIV infection .
1. Binding

2. Reverse Transcription
3. Integration
3. Transcription
5. Translation
6. Viral Assembly and
Maturation
1. Through Body Fluids –
• Blood product
• Semen
• Vaginal Fluid
• Breast milk
2. Through IV drug use
3. Through sex
4. From mother to fetus
and baby
Coughing , sneezing
Insect bites
Water , food
Touching
Kissing
Handshake
Sharing cups , plates, glasses
Playing together
Sharing study materials , office equipments
HIV is not an airborne virus .
Stage 1 : Primary
• Short, flu-like illness - occurs one to six weeks after infection
•

no symptoms at all

Stage 2 :Asymptomatic
• Lasts for an average of ten years
• This stage is free from symptoms

• There may be swollen glands
• The level of HIV in the blood drops to very low levels
• HIV antibodies are detectable in the blood

Stage 3 - Symptomatic
• The symptoms are mild
• The immune system is damaged
• emergence of opportunistic infections and cancers
Stage – 4 : HIV  AIDS

• The immune system weakens
• The illnesses become more severe leading to an AIDS diagnosis

Stage -1

Stage - 2

Stage -3

Stage - 4
 HIV multiply inside CD 4 cell and destroy them .
 Immune system becomes weakened.
 Over time , the ability to fight against infection is lost.
 HIV infected people become vulnerable to opportunistic infections .
That is AIDS .

Kaposi’s
sarcoma, a kind
of skin cancer

Cryptosporidiosis

Opportunistic diseases
take advantage of
weakened immune
systems. These
include…

Pneumocystis
carinii, a kind of
pneumonia

Candidiasis
Dry skin
Fatigue
Fever (comes and goes )
Diarrhea
Frequent vaginal infection
Headache
Mouth sores
Rapid weight loss
Swollen lymph nodes
White spots on tongue, mouth & throat
A sample of blood, urine or a swab of fluids from mouth are taken for the diagnosis .
The tests include –

 HIV antbody test
 PCR test (Polymerase Chain Reaction test) - can detect the genetic
material of HIV
 CD4 count –
600-1200 cells per cubic mm of blood - A healthy person's CD4 count
350-600 – HIV+ person . But HIV medications are typically not indicated.
200 – 350 - the immune system is weakened & medications indicated.
Less than 200 – The patient is classified as having AIDS.

 Viral load – (measures the amount of virus in blood )
 ELISA test
 SPOT test
 WESTERN BLOT test
 Drug resistance
There is ACTUALLY no cure for AIDS .
1. Antiretroviral therapy
- reduce the presence of the virus in the body, but can not
eliminate it.
Nucleoside Reverse Transcriptase inhibitors
(Zidovudine)
Non-Nucleoside Transcriptase inhibitors (Nevirapine)
Protease inhibitor (Ritonavir)
Taking two or more antiretroviral drugs at a time is called
combination therapy. If only one drug was taken, HIV would
quickly become resistant to it.
2. Opportunistic Infection Treatment
Used in an event where antiretroviral drugs are not available
• Protected sex
- use a condom.

• Using New and sterile needle
•
- to significantly reduce the risk of HIV
transmission.
• Avoidance of same gender sex
• Screen all blood and blood products
• Getting medical care during
pregnancy
- to reduce the risk of virus
transmission to baby

PREVENTION IS BETTER
THAN CURE !
Know aids for no AIDS !

Weitere ähnliche Inhalte

Was ist angesagt?

HIV structure,pathogenesis, classification and transmiss
HIV structure,pathogenesis, classification and transmissHIV structure,pathogenesis, classification and transmiss
HIV structure,pathogenesis, classification and transmiss
216191912
 
Infectious Diseases of the Circulatory System
Infectious Diseases of the Circulatory SystemInfectious Diseases of the Circulatory System
Infectious Diseases of the Circulatory System
Jaycris Agnes
 
Tuberculosis final
Tuberculosis   finalTuberculosis   final
Tuberculosis final
Melvin Young
 
Health and disease OCR F212
Health and disease OCR F212Health and disease OCR F212
Health and disease OCR F212
Sanarioz
 
the aids epidemic in africa
the aids epidemic in africathe aids epidemic in africa
the aids epidemic in africa
weepingmarylou
 

Was ist angesagt? (20)

Staging and clinical manifestation of HIV
Staging and clinical manifestation of HIVStaging and clinical manifestation of HIV
Staging and clinical manifestation of HIV
 
Aids
AidsAids
Aids
 
HIV-AIDS. Facts
HIV-AIDS. FactsHIV-AIDS. Facts
HIV-AIDS. Facts
 
Hiv aids project
Hiv aids projectHiv aids project
Hiv aids project
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
HIV structure,pathogenesis, classification and transmiss
HIV structure,pathogenesis, classification and transmissHIV structure,pathogenesis, classification and transmiss
HIV structure,pathogenesis, classification and transmiss
 
Presentation 23 1 (1)
Presentation 23 1 (1)Presentation 23 1 (1)
Presentation 23 1 (1)
 
Hiv dr.tanushka
Hiv dr.tanushkaHiv dr.tanushka
Hiv dr.tanushka
 
Infectious Diseases of the Circulatory System
Infectious Diseases of the Circulatory SystemInfectious Diseases of the Circulatory System
Infectious Diseases of the Circulatory System
 
Tuberculosis final
Tuberculosis   finalTuberculosis   final
Tuberculosis final
 
HIV/ AIDS All Are Including..By Monil Parmar
HIV/ AIDS All Are Including..By Monil  ParmarHIV/ AIDS All Are Including..By Monil  Parmar
HIV/ AIDS All Are Including..By Monil Parmar
 
Health and disease OCR F212
Health and disease OCR F212Health and disease OCR F212
Health and disease OCR F212
 
Immunodeficiency disorder by nom naik
Immunodeficiency disorder by nom naikImmunodeficiency disorder by nom naik
Immunodeficiency disorder by nom naik
 
Aids
AidsAids
Aids
 
the aids epidemic in africa
the aids epidemic in africathe aids epidemic in africa
the aids epidemic in africa
 
Measles, aids, hepatitus
Measles, aids, hepatitusMeasles, aids, hepatitus
Measles, aids, hepatitus
 
Hiv
HivHiv
Hiv
 
Hiv aids & tuberculosis in south africa
Hiv aids & tuberculosis in south africaHiv aids & tuberculosis in south africa
Hiv aids & tuberculosis in south africa
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 

Andere mochten auch

Pharmaceutical labelling
Pharmaceutical labellingPharmaceutical labelling
Pharmaceutical labelling
Kiran Hameed
 

Andere mochten auch (20)

Tablet coating defetcs 1
Tablet coating defetcs 1Tablet coating defetcs 1
Tablet coating defetcs 1
 
Baxan milling
Baxan millingBaxan milling
Baxan milling
 
Anju coatg
Anju coatgAnju coatg
Anju coatg
 
Heat Transfer
Heat TransferHeat Transfer
Heat Transfer
 
Health, medicine and pharmaceutics.
Health, medicine and pharmaceutics.Health, medicine and pharmaceutics.
Health, medicine and pharmaceutics.
 
Acid & Base - Physical Chemistry Presentation
Acid & Base - Physical Chemistry PresentationAcid & Base - Physical Chemistry Presentation
Acid & Base - Physical Chemistry Presentation
 
Filtration
FiltrationFiltration
Filtration
 
Industrial Pharmacy Notes for M.Pharmacy
Industrial Pharmacy Notes for M.PharmacyIndustrial Pharmacy Notes for M.Pharmacy
Industrial Pharmacy Notes for M.Pharmacy
 
Evaporation
EvaporationEvaporation
Evaporation
 
Clinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsClinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural products
 
Nanosuspension
NanosuspensionNanosuspension
Nanosuspension
 
[Paperwork] Mixing - Pharmaceutical Engineering
[Paperwork] Mixing - Pharmaceutical Engineering[Paperwork] Mixing - Pharmaceutical Engineering
[Paperwork] Mixing - Pharmaceutical Engineering
 
Mixing muheem
Mixing muheemMixing muheem
Mixing muheem
 
[Power Point] Mixing - Pharmaceutical Engineering
[Power Point] Mixing - Pharmaceutical Engineering[Power Point] Mixing - Pharmaceutical Engineering
[Power Point] Mixing - Pharmaceutical Engineering
 
Agitation and mixing
Agitation and  mixing Agitation and  mixing
Agitation and mixing
 
Milling machine
Milling machineMilling machine
Milling machine
 
Tablet processing problems and their remedies
Tablet processing problems and their remediesTablet processing problems and their remedies
Tablet processing problems and their remedies
 
Pharmaceutical labelling
Pharmaceutical labellingPharmaceutical labelling
Pharmaceutical labelling
 
Drying
Drying Drying
Drying
 
Tablets
TabletsTablets
Tablets
 

Ähnlich wie Know aids for no AIDS !

Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13
lnguyen
 

Ähnlich wie Know aids for no AIDS ! (20)

HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014
 
Microbial diseases
Microbial diseasesMicrobial diseases
Microbial diseases
 
Final pptct mod 1
Final pptct mod 1Final pptct mod 1
Final pptct mod 1
 
ppt on aids
ppt on aidsppt on aids
ppt on aids
 
352.ppt
352.ppt352.ppt
352.ppt
 
Hiv aids lecture
Hiv aids lectureHiv aids lecture
Hiv aids lecture
 
All blood diseases
All blood diseasesAll blood diseases
All blood diseases
 
HIV infection&AIDS 023.ppt
HIV infection&AIDS 023.pptHIV infection&AIDS 023.ppt
HIV infection&AIDS 023.ppt
 
HIV AIDS_124217.pptx
HIV AIDS_124217.pptxHIV AIDS_124217.pptx
HIV AIDS_124217.pptx
 
Hiv
Hiv Hiv
Hiv
 
microbialdiseasesfor rimc -160303140348.pptx
microbialdiseasesfor rimc -160303140348.pptxmicrobialdiseasesfor rimc -160303140348.pptx
microbialdiseasesfor rimc -160303140348.pptx
 
AIDA Acquired Immuno Deficiency Syndrome
AIDA Acquired Immuno Deficiency Syndrome AIDA Acquired Immuno Deficiency Syndrome
AIDA Acquired Immuno Deficiency Syndrome
 
HIV, ARV
HIV, ARV HIV, ARV
HIV, ARV
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
HIV / AIDS
HIV / AIDSHIV / AIDS
HIV / AIDS
 
Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13Insel10ebrup Ppt Ch13
Insel10ebrup Ppt Ch13
 
2.HIV. AIDS.pptx
2.HIV. AIDS.pptx2.HIV. AIDS.pptx
2.HIV. AIDS.pptx
 
Hiv & pregnancy
Hiv & pregnancyHiv & pregnancy
Hiv & pregnancy
 
Basic facts about HIV/AIDS
Basic facts about HIV/AIDSBasic facts about HIV/AIDS
Basic facts about HIV/AIDS
 
HIV-AIDS.ppt
HIV-AIDS.pptHIV-AIDS.ppt
HIV-AIDS.ppt
 

Kürzlich hochgeladen

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 

Kürzlich hochgeladen (20)

Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 

Know aids for no AIDS !

  • 1. Know AIDS for NO AIDS ! Anika Tabassum Bristy North South University
  • 2.       AIDS - Acquired Immunodeficiency Syndrome Syndrome means – group of diseases Its marked by opportunistic infections It limits the body’s ability to fight infection Final stage of HIV infection No cure
  • 3. EPIDEMIOLOGY Worldwide,  34.2 million people are living with HIV around the world.  1.8 million new cases of HIV in 2010  2.5 million deaths in person with AIDS in 2011.  Nearly 30 million people with AIDS have died worldwide since the epidemic began. Reference - http://aids.com/hiv-basics/basicstatistics/
  • 4.  No of people living with HIV Total 35.3 million [32.2 million – 38.8 million] Adult 32.1 million [29.1 million – 35.3 million] Women 17.7 million [16.4 million – 19.3 million] Children 3.3 million [3.0 million – 3.7 million] • People newly infected with HIV in 2012 Total 2.3 million [1.9 million – 2.7 million] Adult 2.0 million [1.7 million – 2.4 million] Children 260 000 [230 000 – 320 000] AIDS deaths in 2012 - 1.6 million Reference - UNAIDS
  • 5.  The first case of HIV/AIDS in Bangladesh was detected in 1989. HIV and AIDS estimates (2012)      Number of people living with HIV Adults (15 to 49 age ) prevalence rate Adults aged 15 and up living with HIV Women aged 15 and up living with HIV Deaths due to AIDS 8,000 [3,100 - 82,000] - <0.1% [<0.1% - <0.1%] - 7,600 [3,000 - 80,000] - 2,700 [1,000 - 28,000] - <500 [<200 - 2,300] Reference – UNAIDS (http://www.unaids.org/en/regionscountries/countries/bangladesh/)
  • 6. Most affected – USA, South Africa ,Eastern Africa, India Severely affected China , Russia, Brazil, Vietnam Less affected – Australia, Saudi Arabia, Afghanistan
  • 7. • Causative agent – HIV • HIV - “Human Immunodeficiency Virus” • A lentivirus (slowly replicating retrovirus) •Two types of HIV have been characterized – HIV-1 & HIV-2. HIV 1 . HIV 2 Virulence High Lower Infectivity High Low Transmission Easily Less easily Prevalence Global West Africa Development Comparatively fast Slow
  • 8. Professor Luc Montagnier - discovered HIV in 1983. • How HIV causes AIDS ? - HIV destroys a certain kind of blood cell (CD4 + T cells) which is crucial to the normal function of the human immune system. • Loss of these cells in people with HIV leads to the development of AIDS. AIDS is the final state of HIV infection .
  • 9. 1. Binding 2. Reverse Transcription 3. Integration 3. Transcription 5. Translation 6. Viral Assembly and Maturation
  • 10. 1. Through Body Fluids – • Blood product • Semen • Vaginal Fluid • Breast milk 2. Through IV drug use 3. Through sex 4. From mother to fetus and baby
  • 11. Coughing , sneezing Insect bites Water , food Touching Kissing Handshake Sharing cups , plates, glasses Playing together Sharing study materials , office equipments HIV is not an airborne virus .
  • 12. Stage 1 : Primary • Short, flu-like illness - occurs one to six weeks after infection • no symptoms at all Stage 2 :Asymptomatic • Lasts for an average of ten years • This stage is free from symptoms • There may be swollen glands • The level of HIV in the blood drops to very low levels • HIV antibodies are detectable in the blood Stage 3 - Symptomatic • The symptoms are mild • The immune system is damaged • emergence of opportunistic infections and cancers
  • 13. Stage – 4 : HIV  AIDS • The immune system weakens • The illnesses become more severe leading to an AIDS diagnosis Stage -1 Stage - 2 Stage -3 Stage - 4
  • 14.  HIV multiply inside CD 4 cell and destroy them .  Immune system becomes weakened.  Over time , the ability to fight against infection is lost.  HIV infected people become vulnerable to opportunistic infections . That is AIDS . Kaposi’s sarcoma, a kind of skin cancer Cryptosporidiosis Opportunistic diseases take advantage of weakened immune systems. These include… Pneumocystis carinii, a kind of pneumonia Candidiasis
  • 15. Dry skin Fatigue Fever (comes and goes ) Diarrhea Frequent vaginal infection Headache Mouth sores Rapid weight loss Swollen lymph nodes White spots on tongue, mouth & throat
  • 16. A sample of blood, urine or a swab of fluids from mouth are taken for the diagnosis . The tests include –  HIV antbody test  PCR test (Polymerase Chain Reaction test) - can detect the genetic material of HIV  CD4 count – 600-1200 cells per cubic mm of blood - A healthy person's CD4 count 350-600 – HIV+ person . But HIV medications are typically not indicated. 200 – 350 - the immune system is weakened & medications indicated. Less than 200 – The patient is classified as having AIDS.  Viral load – (measures the amount of virus in blood )  ELISA test  SPOT test  WESTERN BLOT test  Drug resistance
  • 17. There is ACTUALLY no cure for AIDS . 1. Antiretroviral therapy - reduce the presence of the virus in the body, but can not eliminate it. Nucleoside Reverse Transcriptase inhibitors (Zidovudine) Non-Nucleoside Transcriptase inhibitors (Nevirapine) Protease inhibitor (Ritonavir) Taking two or more antiretroviral drugs at a time is called combination therapy. If only one drug was taken, HIV would quickly become resistant to it. 2. Opportunistic Infection Treatment Used in an event where antiretroviral drugs are not available
  • 18. • Protected sex - use a condom. • Using New and sterile needle • - to significantly reduce the risk of HIV transmission. • Avoidance of same gender sex • Screen all blood and blood products • Getting medical care during pregnancy - to reduce the risk of virus transmission to baby PREVENTION IS BETTER THAN CURE !